Literature Synthesis for Proposed Intervention

Literature Synthesis
Name
Institution
Course
Professor
Date
Introduction
A continuous glucose-monitoring IoT is an intelligent system gadget that assists people with diabetes conditions to seamlessly monitor the glucose levels in their blood by taking readings at randomized intervals, such as every five minutes, and transferring the data to an app where the user may access it. Medical physicians and caregivers may keep a careful eye on their patients' health with this technique. Doctors can monitor their patients' glucose levels and propose exercise, and, if necessary, medication and conduct analyses. Continuous glucose monitoring (CGM) gives the patient constant access to blood sugar readings, whether throughout the day or night. In addition, it provides information on glucose movements and speeds up the process of supplying patients with additional information to control their diabetes conditions. Without diabetes, the body systems can continuously monitor glucose levels throughout to ensure that the proper amount of insulin is created appropriately, and a CGM operates in the same way. Monitoring the glucose levels in tissue fluids using CGM relies on a glucose sensor, which is a small electrode, is implanted beneath an individual's skin (Polonsky et al., 2017). The majority of the time, it is worn in the abdomen. A needle and a sticky material that functions as an adhesive are used to implant the glucose sensor, which should be changed with a fresh sensor after a few days. The sensor is linked to a transmitter that provides data to a display device through a wireless radiofrequency. The individual will be able to see present and historical glucose level patterns, thanks to the monitor. It can alert a person before their glucose levels reach dangerously high or low levels, as well as if their levels abruptly fall or rise (Polonsky et al., 2017). 
This literature synthesis focuses on the literature identified on CGM, their significance to this DPI intervention (GCM in T1DM patients), and how it may help develop the identified DPI. The studies were collected from various databases, and they all had to meet the criteria of being specific to T1DM management. 
Problem Statement
In adult patients with type 1 diabetes mellitus (T1DM), what is the impact of continuous glucose monitoring (CGM), in comparison to standard self-monitoring of blood glucose (SMBG) levels in reducing hypoglycemic events, enhancing glycemic control, minimizing avoidable hospital readmissions or admissions, and supporting value/cost-effectiveness?
Literature Synthesis
According to Polonsky et al. (2017), Continuous Glucose Monitoring improves diabetes-specific QUALITY OF LIFE (for instance, hypoglycemic confidence and diabetic distress) in persons with T1DM, but the QUALITY OF LIFE measures are not unique to diabetes (such as the health status and well-being of the patients). The majority of QUALITY OF LIFE outcomes were linked to CGM satisfaction but not glycemic results. In 158 persons with poorly managed T1DM, the researchers used a randomized trial of Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes (DIAMOND) to compare CGM to self-monitoring of blood glucose (SMBG). Participants performed QUALIT...